Beaumont Financial Partners, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Beaumont Financial Partners, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$346,000
-6.0%
10,4580.0%0.03%0.0%
Q2 2022$368,000
-23.5%
10,458
+0.1%
0.03%
-10.8%
Q1 2022$481,000
-27.9%
10,450
+3.9%
0.04%
-22.9%
Q4 2021$667,000
+3.1%
10,053
-3.0%
0.05%
-4.0%
Q3 2021$647,000
-24.7%
10,365
-0.0%
0.05%
-23.1%
Q2 2021$859,000
+25.0%
10,368
+0.0%
0.06%
+12.1%
Q1 2021$687,000
-10.9%
10,365
+3.1%
0.06%
-14.7%
Q4 2020$771,000
+78.1%
10,0500.0%0.07%
+65.9%
Q3 2020$433,000
-0.2%
10,0500.0%0.04%
-8.9%
Q2 2020$434,000
+50.7%
10,050
+0.5%
0.04%
+25.0%
Q1 2020$288,000
-54.6%
10,0000.0%0.04%
-41.9%
Q4 2019$634,000
+124.8%
10,0000.0%0.06%
+121.4%
Q3 2019$282,000
+6.4%
10,0000.0%0.03%
+3.7%
Q2 2019$265,000
+44.0%
10,0000.0%0.03%
+35.0%
Q1 2019$184,000
+48.4%
10,0000.0%0.02%0.0%
Q4 2018$124,00010,0000.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders